Díaz‐Jordán, B. L., Cebanu, T., Barcenilla, S. G., & Álvarez‐Román, M. T. (2023). Real‐world experience of rIX‐FP prophylaxis at dosing intervals of up to 14 days in a pediatric patient with hemophilia B during the COVID‐19 pandemic. Clinical Case Reports, 11(12), . https://doi.org/10.1002/ccr3.8180
Chicago-referens (17:e uppl.)Díaz‐Jordán, Bolívar Luis, Tamara Cebanu, Sara García Barcenilla, och Maria Teresa Álvarez‐Román. "Real‐world Experience of RIX‐FP Prophylaxis at Dosing Intervals of Up to 14 Days in a Pediatric Patient with Hemophilia B During the COVID‐19 Pandemic." Clinical Case Reports 11, no. 12 (2023). https://doi.org/10.1002/ccr3.8180.
MLA-referens (9:e uppl.)Díaz‐Jordán, Bolívar Luis, et al. "Real‐world Experience of RIX‐FP Prophylaxis at Dosing Intervals of Up to 14 Days in a Pediatric Patient with Hemophilia B During the COVID‐19 Pandemic." Clinical Case Reports, vol. 11, no. 12, 2023, https://doi.org/10.1002/ccr3.8180.
